Literature DB >> 26407779

Clinical trial methodology and drug-placebo differences.

Irving Kirsch1.   

Abstract

Year:  2015        PMID： 26407779      PMCID： PMC4592646          DOI： 10.1002/wps.20242

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

1.  Are drug and placebo effects in depression additive?

Authors:  I Kirsch
Journal:  Biol Psychiatry       Date:  2000-04-15       Impact factor: 13.382

Review 2.  Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression.

Authors:  Joel R Sneed; Bret R Rutherford; David Rindskopf; David T Lane; Harold A Sackeim; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2007-11-12       Impact factor: 4.105

3.  Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.

Authors:  Bret R Rutherford; Joel R Sneed; Steven P Roose
Journal:  Psychother Psychosom       Date:  2009-03-24       Impact factor: 17.659

Review 4.  Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Authors:  Mark Sinyor; Anthony J Levitt; Amy H Cheung; Ayal Schaffer; Alex Kiss; Yekta Dowlati; Krista L Lanctôt
Journal:  J Clin Psychiatry       Date:  2010-01-26       Impact factor: 4.384

5.  The placebo effect revisited: lessons learned to date.

Authors:  Irving Kirsch
Journal:  Complement Ther Med       Date:  2013-01-05       Impact factor: 2.446

Review 6.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

7.  Antidepressants versus placebo in major depression: an overview.

Authors:  Arif Khan; Walter A Brown
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

8.  Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Authors:  Irving Kirsch; Brett J Deacon; Tania B Huedo-Medina; Alan Scoboria; Thomas J Moore; Blair T Johnson
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069
  8 in total
  3 in total

1.  Raising Placebo Efficacy in Antidepressant Trials Across Decades Explained by Small-Study Effects: A Meta-Reanalysis.

Authors:  Lisa Holper
Journal:  Front Psychiatry       Date:  2020-07-28       Impact factor: 4.157

2.  Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.

Authors:  Christian A Webb; Madhukar H Trivedi; Zachary D Cohen; Daniel G Dillon; Jay C Fournier; Franziska Goer; Maurizio Fava; Patrick J McGrath; Myrna Weissman; Ramin Parsey; Phil Adams; Joseph M Trombello; Crystal Cooper; Patricia Deldin; Maria A Oquendo; Melvin G McInnis; Quentin Huys; Gerard Bruder; Benji T Kurian; Manish Jha; Robert J DeRubeis; Diego A Pizzagalli
Journal:  Psychol Med       Date:  2018-07-02       Impact factor: 7.723

3.  Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders.

Authors:  Elan A Cohen; Howard H Hassman; Larry Ereshefsky; David P Walling; Vera M Grindell; Richard S E Keefe; Katarzyna Wyka; William P Horan
Journal:  Neuropsychopharmacology       Date:  2020-11-26       Impact factor: 7.853
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.